Product Lifecycle Management (PLM) is described as the process of managing the lifecycle of a product (a drug) from innovation, development, and introduction to withdrawal from the market.

Product Lifecycle Management (PLM) is described as the process of managing the lifecycle of a product (a drug) from innovation, development, and introduction to withdrawal from the market.

• A. True
• B. False
• C. Only for biologics
• D. Only during commercialization

Answer: (A)

Product Lifecycle Management describes handling a drug’s entire life—from the initial idea and development through market introduction and eventual withdrawal. It isn’t limited to biologics or to the commercialization phase; PLM integrates all stages, including regulatory changes, manufacturing adjustments, labeling updates, post-market surveillance, and sunset decisions, to optimize value across the whole lifecycle. That breadth is why this statement is correct. The other options mischaracterize PLM by narrowing it to a specific product type or to a single phase of the process.

Product Lifecycle Management describes handling a drug’s entire life—from the initial idea and development through market introduction and eventual withdrawal. It isn’t limited to biologics or to the commercialization phase; PLM integrates all stages, including regulatory changes, manufacturing adjustments, labeling updates, post-market surveillance, and sunset decisions, to optimize value across the whole lifecycle. That breadth is why this statement is correct. The other options mischaracterize PLM by narrowing it to a specific product type or to a single phase of the process.